Back to Results
Meet Ethan Rowin, MD
Title(s)
Co-Director, Hypertrophic Cardiomyopathy Center; Director of Cardiac MR Imaging; Assistant Professor, Tufts University School of Medicine
Department + Services
Medicine, CardioVascular Center, Cardiology
Clinical Focus Areas
Hypertrophic cardiomyopathy, cardiac magnetic resonance imaging (MRI)
Research Focus Areas
Hypertrophic cardiomyopathy, cardiac MRI
Seeing Patients In
Boston, 617-636-8066
Morristown, 973-971-5899
Request Appointment
Tufts Medical Center
South Building, 6th Floor
860 Washington Street
Box 70
Boston, MA 02111
Phone #: 617-636-8066
Fax #: 617-636-7175
|
Morristown Medical Center
First Floor
100 Madison Avenue
Morristown, NJ 07960
Phone #: 973-971-5899
|
1. Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circ Heart Fail. 2014 Nov;7(6):967-75
2. Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. J Am Coll Cardiol. 2015 May:65(18):1915-28
3. Blankstein R, Rowin EJ. What is the best imaging test for patients with hypertrophic cardiomyopathy? It depends on the clinical question! J Cardiovasc Comput Tomogr. 2014 Nov-Dec;8(6):438-41.
4. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 2014 Aug; 130(6):484-95
5. Rowin EJ, Maron MS. The Ever Expanding Spectrum of Phenotypic Diversity in Hypertrophic Cardiomyopathy. Am J Cardiol 2013 Aug 112 (3):463-4
6. Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS. Papillary Muscle Insertion Directly into the Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy, its Identification and Cause of Outflow Obstruction by Cardiac Magnetic Resonance Imaging, and its Surgical Management. Am J Cardiol 2013 Jun 111 (11):1677-9
7. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, Garberich RF, Lesser JR, Appelbaum E, Manning WJ, Maron MS. Risk Stratification and Outcomes of Patients with Hypertrophic Cardiomyopathy over 60 Years of Age. Circulation. 2013 Feb 127 (5): 585-93
8. Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy. Am J Cardiol 2012 Oct 110 (7): 1027-32
9. Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ. Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jul; 5 (4) 441-7
10. Rowin EJ, Maron MS, Lesser JR, Maron BJ. CMR with Late Gadolinium Enhancement in Genotype Positive-Phenotype Negative Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2012 Jan; 5(1):119-22
